The FDA approved the first Alzheimer’s drug that may really work. A Penn physician explains why you probably can’t get it, yet

David Wolk of the Perelman School of Medicine outlines the key takeaways of new Alzheimer’s drug lecanemab.

・ From Philadelphia Inquirer